OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia
Jianan Pan, Hao Lin, Changqian Wang, et al.
Heart and Vessels (2020) Vol. 35, Iss. 10, pp. 1446-1453
Closed Access | Times Cited: 12
Jianan Pan, Hao Lin, Changqian Wang, et al.
Heart and Vessels (2020) Vol. 35, Iss. 10, pp. 1446-1453
Closed Access | Times Cited: 12
Showing 12 citing articles:
Oxidative stress – Complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders
Dragos Rotariu, Elena Emilia Babeş, Delia Mirela Ţiț, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113238-113238
Open Access | Times Cited: 130
Dragos Rotariu, Elena Emilia Babeş, Delia Mirela Ţiț, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113238-113238
Open Access | Times Cited: 130
Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure
Andreas Daiber, Ioanna Andreadou, Matthias Oelze, et al.
Free Radical Biology and Medicine (2020) Vol. 163, pp. 325-343
Open Access | Times Cited: 59
Andreas Daiber, Ioanna Andreadou, Matthias Oelze, et al.
Free Radical Biology and Medicine (2020) Vol. 163, pp. 325-343
Open Access | Times Cited: 59
The potential relationship of coronary artery disease and hyperuricemia: A cardiometabolic risk factor
Kaiyue Li, Kongwei Li, Qingmei Yao, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e16097-e16097
Open Access | Times Cited: 17
Kaiyue Li, Kongwei Li, Qingmei Yao, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e16097-e16097
Open Access | Times Cited: 17
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 450-450
Open Access | Times Cited: 7
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 450-450
Open Access | Times Cited: 7
Redox signaling in heart failure and therapeutic implications
David Weissman, Christoph Maack
Free Radical Biology and Medicine (2021) Vol. 171, pp. 345-364
Closed Access | Times Cited: 38
David Weissman, Christoph Maack
Free Radical Biology and Medicine (2021) Vol. 171, pp. 345-364
Closed Access | Times Cited: 38
Inflammaging, a targetable pathway for preventing cardiovascular diseases
Juan Aranda, Cristina M. Ramírez, Marı́a Mittelbrunn
Cardiovascular Research (2024)
Open Access | Times Cited: 3
Juan Aranda, Cristina M. Ramírez, Marı́a Mittelbrunn
Cardiovascular Research (2024)
Open Access | Times Cited: 3
Uric acid-lowering therapy with benzbromarone in hypertension with asymptomatic hyperuricemia: a randomized study focusing left ventricular diastolic function
Jiahan Ke, Jianan Pan, Hao Lin, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 7, pp. 947-953
Closed Access | Times Cited: 4
Jiahan Ke, Jianan Pan, Hao Lin, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 7, pp. 947-953
Closed Access | Times Cited: 4
Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Jun Gu, Zhaofang Yin, Zuojun Xu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 8
Jun Gu, Zhaofang Yin, Zuojun Xu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 8
Greater coronary lipid core plaque assessed by near-infrared spectroscopy intravascular ultrasound in patients with elevated xanthine oxidoreductase: a mechanistic insight
Yuichi Saito, Naoto Mori, Takayo Murase, et al.
Heart and Vessels (2020) Vol. 36, Iss. 5, pp. 597-604
Closed Access | Times Cited: 7
Yuichi Saito, Naoto Mori, Takayo Murase, et al.
Heart and Vessels (2020) Vol. 36, Iss. 5, pp. 597-604
Closed Access | Times Cited: 7
Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort
Marcin Wełnicki, Iwona Gorczyca−Michta, Arkadiusz Lubas, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 12, pp. 7288-7288
Open Access | Times Cited: 4
Marcin Wełnicki, Iwona Gorczyca−Michta, Arkadiusz Lubas, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 12, pp. 7288-7288
Open Access | Times Cited: 4
Study of left ventricular systolic dysfunction, left ventricular diastolic dysfunction and pulmonary hypertension in CKD 3b-5ND patients—A single centre cross-sectional study
Shivendra Kumar Singh, Vikas Aggarwal, Umesh Kumar Pandey, et al.
Nefrología (English Edition) (2022) Vol. 43, Iss. 5, pp. 596-605
Open Access | Times Cited: 4
Shivendra Kumar Singh, Vikas Aggarwal, Umesh Kumar Pandey, et al.
Nefrología (English Edition) (2022) Vol. 43, Iss. 5, pp. 596-605
Open Access | Times Cited: 4
Study of left ventricular systolic dysfunction, left ventricular diastolic dysfunction and pulmonary hypertension in CKD 3b-5ND patients—A single centre cross-sectional study
Shivendra Singh, Vikas Aggarwal, Umesh Kumar Pandey, et al.
Nefrología (2022) Vol. 43, Iss. 5, pp. 596-605
Open Access | Times Cited: 1
Shivendra Singh, Vikas Aggarwal, Umesh Kumar Pandey, et al.
Nefrología (2022) Vol. 43, Iss. 5, pp. 596-605
Open Access | Times Cited: 1
